Consent timing and experience: modifiable factors that may influence interest in clinical research
Low rates of participation in cancer clinical trials have been attributed to patient, institutional, and study characteristics. However, few studies have examined factors related to the consent process. We therefore evaluated the impact of consent timing and experience on markers of patient interest...
Saved in:
Published in: | Journal of oncology practice Vol. 8; no. 2; pp. 91 - 96 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
American Society of Clinical Oncology
01-03-2012
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Low rates of participation in cancer clinical trials have been attributed to patient, institutional, and study characteristics. However, few studies have examined factors related to the consent process. We therefore evaluated the impact of consent timing and experience on markers of patient interest in research.
We performed a retrospective analysis of patients enrolled in a cancer center tissue repository. During enrollment, patients were asked if they were willing to be contacted in the future to provide medical follow-up information and/or to participate in other clinical research. We analyzed the association between patient responses to these questions and consent process factors using univariate analysis and multivariate logistic regression.
Of 922 patients evaluated, 85% agreed to be contacted to provide follow-up information, and 83% agreed to be contacted to participate in future research studies. In univariate analysis, willingness to be contacted for future research was associated with consenter experience (P = .01) and had a trend toward association with the timing of enrollment in relation to diagnosis (P = .08), but it was not associated with patient sex, race, or diagnosis. In multivariate analysis, responses remained associated with consenter experience (P = .02).
Factors related to the consent process, including consenter experience and timing of study enrollment, are significantly associated with or have a trend toward association with markers of patient interest in clinical research. These understudied and potentially modifiable variables warrant further evaluation. |
---|---|
AbstractList | Factors related to the consent process, including consenter experience and timing of study enrollment, are significantly associated with or have a trend toward association with markers of patient interest in clinical research. PURPOSELow rates of participation in cancer clinical trials have been attributed to patient, institutional, and study characteristics. However, few studies have examined factors related to the consent process. We therefore evaluated the impact of consent timing and experience on markers of patient interest in research. METHODSWe performed a retrospective analysis of patients enrolled in a cancer center tissue repository. During enrollment, patients were asked if they were willing to be contacted in the future to provide medical follow-up information and/or to participate in other clinical research. We analyzed the association between patient responses to these questions and consent process factors using univariate analysis and multivariate logistic regression. RESULTSOf 922 patients evaluated, 85% agreed to be contacted to provide follow-up information, and 83% agreed to be contacted to participate in future research studies. In univariate analysis, willingness to be contacted for future research was associated with consenter experience (P = .01) and had a trend toward association with the timing of enrollment in relation to diagnosis (P = .08), but it was not associated with patient sex, race, or diagnosis. In multivariate analysis, responses remained associated with consenter experience (P = .02). CONCLUSIONFactors related to the consent process, including consenter experience and timing of study enrollment, are significantly associated with or have a trend toward association with markers of patient interest in clinical research. These understudied and potentially modifiable variables warrant further evaluation. Low rates of participation in cancer clinical trials have been attributed to patient, institutional, and study characteristics. However, few studies have examined factors related to the consent process. We therefore evaluated the impact of consent timing and experience on markers of patient interest in research. We performed a retrospective analysis of patients enrolled in a cancer center tissue repository. During enrollment, patients were asked if they were willing to be contacted in the future to provide medical follow-up information and/or to participate in other clinical research. We analyzed the association between patient responses to these questions and consent process factors using univariate analysis and multivariate logistic regression. Of 922 patients evaluated, 85% agreed to be contacted to provide follow-up information, and 83% agreed to be contacted to participate in future research studies. In univariate analysis, willingness to be contacted for future research was associated with consenter experience (P = .01) and had a trend toward association with the timing of enrollment in relation to diagnosis (P = .08), but it was not associated with patient sex, race, or diagnosis. In multivariate analysis, responses remained associated with consenter experience (P = .02). Factors related to the consent process, including consenter experience and timing of study enrollment, are significantly associated with or have a trend toward association with markers of patient interest in clinical research. These understudied and potentially modifiable variables warrant further evaluation. |
Author | Gerber, David E Sayne, Jennifer R Xie, Yang Dowell, Jonathan E Skinner, Celette Sugg Rasco, Drew W Yan, Jingsheng |
Author_xml | – sequence: 1 givenname: David E surname: Gerber fullname: Gerber, David E organization: University of Texas Southwestern Medical Center, Dallas, TX – sequence: 2 givenname: Drew W surname: Rasco fullname: Rasco, Drew W – sequence: 3 givenname: Celette Sugg surname: Skinner fullname: Skinner, Celette Sugg – sequence: 4 givenname: Jonathan E surname: Dowell fullname: Dowell, Jonathan E – sequence: 5 givenname: Jingsheng surname: Yan fullname: Yan, Jingsheng – sequence: 6 givenname: Jennifer R surname: Sayne fullname: Sayne, Jennifer R – sequence: 7 givenname: Yang surname: Xie fullname: Xie, Yang |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23077435$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkc1PAyEUxInRqFXP3gxHL1thgVI8mJjGz5joQRNvhGUfFrMLFbZG_3tpqkZPTODHvDeZEdoMMQBCh5SMaU3Iye39w7gmlI4JIYyJDbRLFRMVn6jnzaKF4JXkUu6gUc6vhHCh1GQb7dSMSMmZ2EXNLIYMYcCD7314wSa0GD4WkDwEC6e4j6133jQdYGfsEFPGw9wMuDef2AfXLVdYUQMkyEMR2HY-eGs6XC7AJDvfR1vOdBkOvs899HR58Ti7ru7ur25m53eVZYoNVdNMJ3XdcKrA2RKJ1bwlVoEUXBIqJoSpqWNgXcGNFA3UbStKCMIs541ybA-drX0Xy6aH1pZUyXR6kXxv0qeOxuv_L8HP9Ut814wLOWWiGBx_G6T4tixxdO-zha4zAeIya1qWUlMieV3QkzVqU8w5gfsdQ4leNaNLM3rVjF43U34c_d3ul_-pgn0B-rCNJA |
CitedBy_id | crossref_primary_10_1016_j_cllc_2019_07_008 crossref_primary_10_1016_j_cct_2022_106922 crossref_primary_10_1177_1740774520939247 crossref_primary_10_1016_j_jtho_2017_07_020 crossref_primary_10_1016_j_cllc_2020_12_001 crossref_primary_10_1007_s13539_014_0128_z crossref_primary_10_1016_j_cllc_2017_04_012 crossref_primary_10_1097_SLA_0000000000001483 crossref_primary_10_1200_JCO_19_00101 crossref_primary_10_1634_theoncologist_2015_0083 crossref_primary_10_1016_j_conctc_2020_100532 crossref_primary_10_1089_bio_2013_0083 crossref_primary_10_1111_jonm_12248 crossref_primary_10_1093_jnci_djv002 crossref_primary_10_1093_jnci_dju302 crossref_primary_10_1200_JOP_2016_013060 |
Cites_doi | 10.1001/jama.291.22.2720 10.1136/bmj.38366.562685.8F 10.1093/annonc/mdn623 10.1200/JCO.2001.19.6.1728 10.1002/1097-0142(20010101)91:1+<233::AID-CNCR10>3.0.CO;2-8 10.1002/cncr.22319 10.1080/02841860600849067 10.1097/00000421-199902000-00011 10.1002/cncr.11213 10.1200/JCO.2003.08.010 10.1002/cncr.22436 10.1200/JCO.2003.02.105 10.1016/S0140-6736(02)07810-8 10.1136/jme.2002.001461 10.1200/JCO.2007.14.8114 10.1200/JCO.2003.08.031 10.1002/cncr.21613 10.1002/cncr.23170 10.1001/jama.292.13.1593 10.1001/jama.1983.03340190048030 10.1016/S0277-9536(00)00178-7 10.1542/peds.85.1.58 10.1093/jnci/83.4.254 10.1001/archinte.167.5.453 10.1200/JCO.2004.02.175 10.1634/theoncologist.2008-0268 10.1016/S0895-4356(97)00240-0 10.1007/BF02599693 10.1016/j.ijrobp.2007.01.051 |
ContentType | Journal Article |
Copyright | Copyright © 2011 by American Society of Clinical Oncology 2011 |
Copyright_xml | – notice: Copyright © 2011 by American Society of Clinical Oncology 2011 |
DBID | NPM AAYXX CITATION 7X8 5PM |
DOI | 10.1200/JOP.2011.000335 |
DatabaseName | PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic PubMed |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1935-469X |
EndPage | 96 |
ExternalDocumentID | 10_1200_JOP_2011_000335 23077435 |
Genre | Journal Article |
GrantInformation_xml | – fundername: NCRR NIH HHS grantid: KL2 RR024983 – fundername: NCI NIH HHS grantid: P30 CA142543 |
GroupedDBID | --- 18M 29L 2WC 39C 4.4 5GY 5VS AAQQT AAWTL ABDBF ABJNI ACGFO ACGFS ADBBV AEGXH AIAGR ALMA_UNASSIGNED_HOLDINGS BAWUL C45 CS3 DIK E3Z EBS EJD ESX F5P F9R FBNNL GX1 H13 HZ~ J5H KQ8 NPM O9- OK1 OVD P2P RHF RHI RUC SV3 TEORI TR2 W8F WOQ AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c393t-bb8622b419efc011324d0c9e754701560398f3ecfc39a75be2dd574303c44b9f3 |
ISSN | 1554-7477 |
IngestDate | Tue Sep 17 21:28:20 EDT 2024 Sat Aug 17 00:14:12 EDT 2024 Thu Nov 21 21:04:14 EST 2024 Sat Sep 28 08:07:36 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Issue | 2 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c393t-bb8622b419efc011324d0c9e754701560398f3ecfc39a75be2dd574303c44b9f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://europepmc.org/articles/pmc3457835?pdf=render |
PMID | 23077435 |
PQID | 1113980742 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3457835 proquest_miscellaneous_1113980742 crossref_primary_10_1200_JOP_2011_000335 pubmed_primary_23077435 |
PublicationCentury | 2000 |
PublicationDate | 2012-03-01 |
PublicationDateYYYYMMDD | 2012-03-01 |
PublicationDate_xml | – month: 03 year: 2012 text: 2012-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Alexandria, VA |
PublicationTitle | Journal of oncology practice |
PublicationTitleAlternate | J Oncol Pract |
PublicationYear | 2012 |
Publisher | American Society of Clinical Oncology |
Publisher_xml | – name: American Society of Clinical Oncology |
References | 2296494 - Pediatrics. 1990 Jan;85(1):58-62 19401521 - Oncologist. 2009 May;14(5):468-75 17200964 - Cancer. 2007 Feb 1;109(3):465-76 15187053 - JAMA. 2004 Jun 9;291(22):2720-6 2795264 - J Gen Intern Med. 1989 Sep-Oct;4(5):410-2 18922881 - Ann Oncol. 2009 Feb;20(2):379-85 18008353 - Cancer. 2008 Jan 1;112(1):212-9 11879860 - Lancet. 2002 Feb 23;359(9307):650-6 11148585 - Cancer. 2001 Jan 1;91(1 Suppl):233-6 12610181 - J Clin Oncol. 2003 Mar 1;21(5):830-5 15542812 - J Clin Oncol. 2004 Nov 15;22(22):4626-31 17353492 - Arch Intern Med. 2007 Mar 12;167(5):453-60 9474067 - J Clin Epidemiol. 1998 Feb;51(2):69-79 15467062 - JAMA. 2004 Oct 6;292(13):1593-601 10025379 - Am J Clin Oncol. 1999 Feb;22(1):42-6 14872080 - J Med Ethics. 2004 Feb;30(1):73-9 12663731 - J Clin Oncol. 2003 Apr 1;21(7):1383-9 12627515 - Cancer. 2003 Mar 15;97(6):1499-506 17078056 - Cancer. 2006 Dec 1;107(11):2669-77 11251003 - J Clin Oncol. 2001 Mar 15;19(6):1728-33 12915605 - J Clin Oncol. 2003 Aug 15;21(16):3141-9 11218181 - Soc Sci Med. 2001 Mar;52(5):797-808 16397866 - Cancer. 2006 Jan 15;106(2):258-70 18509178 - J Clin Oncol. 2008 Jun 1;26(16):2666-73 6632164 - JAMA. 1983 Nov 18;250(19):2646-8 17438704 - Acta Oncol. 2007;46(1):42-8 17418963 - Int J Radiat Oncol Biol Phys. 2007 Jul 15;68(4):1145-50 1994054 - J Natl Cancer Inst. 1991 Feb 20;83(4):254-9 15705666 - BMJ. 2005 Feb 19;330(7488):400 B20 B21 B22 B23 B25 B26 B27 B28 B29 Tarnowski KJ (B24) 1990; 85 B10 B11 B12 B13 B14 B15 B16 B17 B18 B19 B1 B2 B3 B4 B5 B6 B7 B8 B9 |
References_xml | – ident: B3 doi: 10.1001/jama.291.22.2720 – ident: B17 doi: 10.1136/bmj.38366.562685.8F – ident: B21 doi: 10.1093/annonc/mdn623 – ident: B4 doi: 10.1200/JCO.2001.19.6.1728 – ident: B8 doi: 10.1002/1097-0142(20010101)91:1+<233::AID-CNCR10>3.0.CO;2-8 – ident: B10 doi: 10.1002/cncr.22319 – ident: B20 doi: 10.1080/02841860600849067 – ident: B26 doi: 10.1097/00000421-199902000-00011 – ident: B7 doi: 10.1002/cncr.11213 – ident: B5 doi: 10.1200/JCO.2003.08.010 – ident: B11 doi: 10.1002/cncr.22436 – ident: B29 doi: 10.1200/JCO.2003.02.105 – ident: B16 doi: 10.1016/S0140-6736(02)07810-8 – ident: B28 doi: 10.1136/jme.2002.001461 – ident: B14 doi: 10.1200/JCO.2007.14.8114 – ident: B18 doi: 10.1200/JCO.2003.08.031 – ident: B27 doi: 10.1002/cncr.21613 – ident: B1 doi: 10.1002/cncr.23170 – ident: B15 doi: 10.1001/jama.292.13.1593 – ident: B23 doi: 10.1001/jama.1983.03340190048030 – ident: B25 doi: 10.1016/S0277-9536(00)00178-7 – volume: 85 start-page: 58 year: 1990 ident: B24 publication-title: Pediatrics doi: 10.1542/peds.85.1.58 contributor: fullname: Tarnowski KJ – ident: B2 doi: 10.1093/jnci/83.4.254 – ident: B19 doi: 10.1001/archinte.167.5.453 – ident: B6 doi: 10.1200/JCO.2004.02.175 – ident: B13 doi: 10.1634/theoncologist.2008-0268 – ident: B12 doi: 10.1016/S0895-4356(97)00240-0 – ident: B22 doi: 10.1007/BF02599693 – ident: B9 doi: 10.1016/j.ijrobp.2007.01.051 |
SSID | ssj0045996 |
Score | 1.6583195 |
Snippet | Low rates of participation in cancer clinical trials have been attributed to patient, institutional, and study characteristics. However, few studies have... Factors related to the consent process, including consenter experience and timing of study enrollment, are significantly associated with or have a trend toward... PURPOSELow rates of participation in cancer clinical trials have been attributed to patient, institutional, and study characteristics. However, few studies... |
SourceID | pubmedcentral proquest crossref pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 91 |
SubjectTerms | Original Contributions |
Title | Consent timing and experience: modifiable factors that may influence interest in clinical research |
URI | https://www.ncbi.nlm.nih.gov/pubmed/23077435 https://search.proquest.com/docview/1113980742 https://pubmed.ncbi.nlm.nih.gov/PMC3457835 |
Volume | 8 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9swEBdpB2MvY91n9oUGexgMb7ElV9beRpvSsa4pWwp5M5YsN3moXRrn_9-d9WGnpdA97MUYx1EU3Y_T3enud4R8LBTswZKBW7IvJhEvRRVlBTiuKVNMxqbMtMDi5OM_4nSRHU75dDTyWUv9s_8qaXgGssbK2X-QdhgUHsA9yByuIHW43kvu2IETz_dbbNdl6w9NoDNG__-yKVfVqquY8s122mXRfr4ssATQtSzpaCSwbQfGQ0L1pGMGWt5h0Ta1toxOvvQqJPeA7Cw0uhT6vvrhd7HWXaz28BrZ_UO4p-8IdgDbYtsaUHAXF8Hobnwqt4_9uxFd9ALTQHz61hdjNa5kaQQ--mKokrMB8pKBepXxYKO2nXBvbQGJ7W49O3P8rNitLu13O3_CfzrLj85PTvL5dDHfIQ8S0FOdR_7jp9_IOTLXODYoGPTrjSG3DZlb3snNJNuB1TJ_Qh474dDvFid7ZGTqp-ThL5dQ8YwoBxdq4UIBLrSHyzfag4U6sFAECwWw0AAW6sECN9SDhXqwPCfnR9P5wXHk2m5EmknWRkqBl5soHktTafi_YHKXEy2NSLnoCu-ZzCpmdAWvFyJVJinLFAzRCdOcK1mxF2S3bmrzitBYVrwAgxeNWI5kcDpWKtGTquRKlcKMySe_hvmVZVfJ0StN8Ih1dpbjcud2ucfkg1_jHDQgHmsVtWk2a_RhYUYY4xmTl3bNw2BY5gBTg2-LLWmEF5BdffuTerXsWNZhwhgVfX2P331DHvXYfkt22-uNeUd21uXmfYeov98Vmzc |
link.rule.ids | 230,315,782,786,887,27933,27934 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Consent+timing+and+experience%3A+modifiable+factors+that+may+influence+interest+in+clinical+research&rft.jtitle=Journal+of+oncology+practice&rft.au=Gerber%2C+David+E&rft.au=Rasco%2C+Drew+W&rft.au=Skinner%2C+Celette+Sugg&rft.au=Dowell%2C+Jonathan+E&rft.date=2012-03-01&rft.eissn=1935-469X&rft.volume=8&rft.issue=2&rft.spage=91&rft.epage=96&rft_id=info:doi/10.1200%2FJOP.2011.000335&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1554-7477&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1554-7477&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1554-7477&client=summon |